Vaneck Biotech Etf Performance
| BBH Etf | USD 151.99 1.02 0.67% |
The entity has a beta of 1.11, which indicates a somewhat significant risk relative to the market. VanEck Biotech returns are very sensitive to returns on the market. As the market goes up or down, VanEck Biotech is expected to follow.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days VanEck Biotech ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Etf's fundamental drivers remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the Etf traders. ...more
1 | Should You Invest in the VanEck Biotech ETF - Yahoo Finance | 02/12/2024 |
2 | Should You Invest in the VanEck Biotech ETF | 04/15/2024 |
| In Threey Sharp Ratio | -0.13 |
VanEck |
VanEck Biotech Relative Risk vs. Return Landscape
If you would invest 16,667 in VanEck Biotech ETF on January 20, 2024 and sell it today you would lose (1,468) from holding VanEck Biotech ETF or give up 8.81% of portfolio value over 90 days. VanEck Biotech ETF is generating negative expected returns assuming volatility of 0.9748% on return distribution over 90 days investment horizon. In other words, 8% of etfs are less volatile than VanEck, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
VanEck Biotech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for VanEck Biotech's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as VanEck Biotech ETF, and traders can use it to determine the average amount a VanEck Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1452
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BBH |
Estimated Market Risk
| 0.97 actual daily | 8 92% of assets are more volatile |
Expected Return
| -0.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average VanEck Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VanEck Biotech by adding VanEck Biotech to a well-diversified portfolio.
VanEck Biotech Fundamentals Growth
VanEck Etf prices reflect investors' perceptions of the future prospects and financial health of VanEck Biotech, and VanEck Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on VanEck Etf performance.
| Price To Earning | 17.66 X | |||
| Price To Book | 2.74 X | |||
| Price To Sales | 4.72 X | |||
| Total Asset | 478.42 M | |||
About VanEck Biotech Performance
To evaluate VanEck Biotech ETF Etf as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when VanEck Biotech generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare VanEck Etf's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand VanEck Biotech ETF market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents VanEck's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index. Vaneck Biotech is traded on NASDAQ Exchange in the United States.| VanEck Biotech ETF generated a negative expected return over the last 90 days | |
| Latest headline from zacks.com: Should You Invest in the VanEck Biotech ETF | |
| The fund generated three year return of -6.0% | |
| VanEck Biotech ETF holds 99.96% of its assets under management (AUM) in equities |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in VanEck Biotech ETF. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the VanEck Biotech ETF information on this page should be used as a complementary analysis to other VanEck Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.